Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 53.50 GBp
Change Today 0.00 / 0.00%
Volume 0.0
REVO On Other Exchanges
As of 12:35 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

revolymer plc (REVO) Snapshot

53.50 GBp
Previous Close
53.50 GBp
Day High
53.50 GBp
Day Low
53.50 GBp
52 Week High
09/29/14 - 63.00 GBp
52 Week Low
05/19/14 - 48.50 GBp
Market Cap
Average Volume 10 Days
-0.10 GBp
Shares Outstanding
Dividend Yield
Current Stock Chart for REVOLYMER PLC (REVO)

Related News

No related news articles were found.

revolymer plc (REVO) Related Businessweek News

No Related Businessweek News Found

revolymer plc (REVO) Details

Revolymer plc, a technology company, designs, develops, and formulates polymers in the United Kingdom, Ireland, Canada, Italy, and the United States. Its technologies are used in household products, personal care products, and coatings and adhesives product areas, as well as in medicated chewing gums, including nicotine gums and confectionery chewing gums. The company was incorporated in 2012 and is headquartered in Flintshire, the United Kingdom.

41 Employees
Last Reported Date: 04/23/14
Founded in 2012

revolymer plc (REVO) Top Compensated Officers

Chief Financial Officer, Secretary and Direct...
Total Annual Compensation: 180.0K GBP
Compensation as of Fiscal Year 2013.

revolymer plc (REVO) Key Developments

Revolymer plc Announces Settlement and Discontinuation of Patent Infringement Proceedings

In respect of the alleged patent infringement action brought by Fertin Pharma A/S and Gumlink A/S against Revolymer plc relating to the sale of its nicotine gum products in Canada, Revolymer announced that the Action, and the counterclaim forming part of Revolymer's defence, has been settled and discontinued.

Revolymer plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended 30 June 2014

Revolymer plc announced unaudited consolidated earnings results for the six months ended 30 June 2014. For the period, revenue was GBP 366,000 against GBP 22,000 a year ago. Operating loss was GBP 2,748,000 against GBP 2,959,000 a year ago. Loss for the period before tax was GBP 2,691,000 against GBP 2,854,000 a year ago. Loss for the period was GBP 2,691,000 or 4.8 pence per basic and diluted share against GBP 2,854,000 or 5.3 pence per basic and diluted share a year ago. Net cash outflow from operating activities was GBP 2,550,000 against GBP 2,154,000 a year ago. Purchase of property, plant and equipment was GBP 126,000 against GBP 129,000 a year ago.

Revolymer Signs Global Licence with Solvay

Revolymer announced that it has signed the first license in its prioritized Consumer Specialties business area with the international chemicals group Solvay. Under the terms of the deal, Solvay has exclusive rights to apply Revolymer's encapsulation technology to its proprietary cleaning and disinfecting active ingredient 6-phthalimido-peroxyhexanoic acid, known as PAP and commercialized currently by Solvay under the trade mark Eureco(TM). It is intended that the resultant formulations of PAP will be more stable than existing PAP formats marketed by Solvay, thereby expanding the market for this active into a broad range of fields including cleaning, disinfection and deodorization in both solid, gel and liquid product formats. The geographic territory of the license is global, and Solvay intends to target industry segments including laundry detergents and additives and dish wash agents, in the consumer, domestic, industrial and institutional markets. Veterinary, pharmaceutical and other health care applications are also included in the deal. As consideration for the license, Solvay will make royalty payments to Revolymer on net sales of PAP products incorporating Revolymer technology.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REVO:LN 53.50 GBp 0.00

REVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for REVO.
View Industry Companies

Industry Analysis


Industry Average

Valuation REVO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 29.7x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REVOLYMER PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at